Repair of the oxidative DNA damage 8-oxoguanine as a biomarker for lung cancer risk

Cancer Biomarkers

Volumn 1, Issue 2-3, 2005, Pages 201-205

  Paz Elizur, Tamar ^a   Krupsky, Meir ^b   Elinger, Dalia ^a   Schechtman, Edna ^c   Livneh, Zvi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; 8-HYDROXYGUANINE; DNA GLYCOSYLTRANSFERASE; DRUG DERIVATIVE; GUANINE; OXOGUANINE GLYCOSYLASE 1, HUMAN; TUMOR MARKER;

DISEASE PREDISPOSITION; DNA DAMAGE; DNA REPAIR; ENZYMOLOGY; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; METHODOLOGY; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW; RISK ASSESSMENT;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE SUSCEPTIBILITY; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; GUANINE; HUMANS; LUNG NEOPLASMS; OXIDATIVE STRESS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 33845741277     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2005-12-308     Document Type: Article

References (36)

1. B. Vogelstein and K.W. Kinzler, The genetic basis of human cancer, McGraw-Hill New York NY, 1998.
2. E.C. Friedberg, G.C. Walker and W. Siede, DNA repair and mutagenesis, ASM Press Washington, D.C., 1995.
3. R.D. Wood, M. Mitchell, J. Sgouros and T. Lindahl, Human DNA repair genes, Science 291 (2001), 1284-1289.
4. A. Sancar, Mechanisms of DNA repair, Science 266 (1994), 1954-1956.
5. W.L. de Laat, N.G. Jaspers and J.H. Hoeijmakers, Molecular mechanism of nucleotide excision repair, Genes Dev 13 (1999), 768-785.
6. E. Seeberg, L. Eide and M. Bjoras, The base excision repair pathway, Trends Biochem. Sci. 20 (1995), 391-397.
7. G.P. Margison and M.F. Santibanez-Koref, O6-alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy, Bioessays 24 (2002), 255-266.
8. P. Modrich, Mismatch repair, genetic stability, and cancer, Science 266 (1994), 1959-1960.
9. S.P. Jackson, Sensing and repairing DNA double-strand breaks, Carcinogenesis 23 (2002), 687-696.
10. K. Valerie and L.F. Povirk, Regulation and mechanisms of mammalian double-strand break repair, Oncogene 22 (2003), 5792-5812.
11. Z. Livneh, DNA damage control by novel DNA polymerases: translesion replication and mutagenesis, J. Biol. Chem. 276 (2001), 25639-25642.
12. S. Prakash and L. Prakash, Translesion DNA synthesis in eukaryotes: A one-or two-polymerase affair, Genes Dev. 16 (2002), 1872-1883.
13. O.M. Sieber, L. Lipton, M. Crabtree, K. Heinimann, P. Fidalgo, R.K. Phillips, M.L. Bisgaard, T.F. Orntoft, L.A. Aaltonen, S.V. Hodgson, H.J. Thomas and I.P. Tomlinson, Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH, N. Engl. J. Med. 348 (2003), 791-799.
14. L.C. Gowen, A.V. Avrutskaya, A.M. Latour, B.H. Koller and S.A. Leadon, BRCA1 required for transcription-coupled repair of oxidative DNA damage, Science 281 (1998), 1009-1012.
15. K.J. Patel, V.P.C.C. Yu, H. Lee, A. Corcoran, F.C. Thistlethwaite, M.J. Evans,W.H. Colledge, L.S. Friedman, B.A.J. Ponder and A.R. Venkitaraman, Involvement of Brca2 in DNA Repair, Mol. Cell 1 (1998), 347-357.
16. F. Le Page, V. Randrianarison, D. Marot, J. Cabannes, M. Perricaudet, J. Feunteun and A. Sarasin, BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells, Cancer Res. 60 (2000), 5548-5552.
17. M. Berwick and P. Vineis, Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review, J. Natl. Cancer Inst. 92 (2000), 874-897.
18. M.R. Spitz, Q. Wei, Q. Dong, C.I. Amos and X. Wu, Genetic susceptibility to lung cancer: the role of DNA damage and repair, Cancer Epidemiol. Biomarkers Prev. 12 (2003), 689-698.
19. S.M. Lippman and M.R. Spitz, Lung cancer chemoprevention: An integrated approach, J. Clin. Oncol. 19 (2001), 74s-82s.
20. Q. Wei, L. Cheng, C.I. Amos, L.-E. Wang, Z. Guo, W.K. Hong and M.R. Spitz, Repair of tobacco carcinogen-induced DNAadducts and lung cancer risk: a molecular epidemiologic study, J. Natl. Cancer Inst. 92 (2000), 1764-1772.
21. W.F. Athas, M.A. Hedayati, G.M. Matanoski, E.R. Farmer and L. Grossman, Development and field-test validation of an assay for DNA repair in circulating human lymphocytes, Cancer Res. 51 (1991), 5786-5793.
22. N. Rajaee-Behbahani, P. Schmezer, A. Risch, W. Rittgen, K.W. Kayser, H. Dienemann, V. Schultz, P. Drings, S. Thiel and H. Bartsch, Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer, Int. J. Cancer (Pred. Oncol.) 95 (2001), 86-91.
23. E.L. Goode, C.M. Ulrich and J.D. Potter, Polymorphisms in DNA repair genes and associations with cancer risk, Cancer Epidemiol. Biomarkers Prev. 11 (2002), 1513-1530.
24. J. Park, L. Chen, M.S. Tockman, A. Elahi and P. Lazarus, The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk, Pharmacogenetics 14 (2004), 103-109.
25. N.R. Jacobsen, O. Raaschou-Nielsen, B. Nexo, H. Wallin, K. Overvad, A. Tjonneland and U. Vogel, XRCC3 polymorphisms and risk of lung cancer, Cancer Lett. 213 (2004), 67-72.
26. M. Esteller and J.G. Herman, Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours, J. Pathol. 196 (2002), 1-7.
27. T. Paz-Elizur, M. Krupsky, S. Blumenstein, D. Elinger, E. Schechtman and Z. Livneh, Reduced DNA repair activity for oxidative damage and the risk of lung cancer, J. Natl. Cancer Inst. 95 (2003), 1312-1319.
28. H. Kasai and S. Nishimura, Formation of 8-hydroxydeoxyguanosine in DNA by oxygen radicals and its biological significance, in: Oxidative stress: Oxidants and antioxidants, H. Sies, Editor, 1991, Academic Press: London. pp. 99-116.
29. J. Cadet, T. Douki, D. Gasparutto and J.L. Ravanat, Oxidative damage to DNA: formation, measurement and biochemical features, Mutat. Res. 531 (2003), 5-23.
30. S. Asami, H. Manabe, J. Miyake, Y. Tsurudome, T. Hirano, R. Yamaguchi, H. Itoh and H. Kasai, Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung, Carcinogenesis 18 (1997), 1763-1766.
31. S. Boiteux and J.P. Radicella, The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis, Arch. Biochem. Biophys. 377 (2000), 1-8.
32. H. Wikman, A. Risch, F. Klimek, P. Schmezer, B. Spiegelhalder, H. Dienemann, K. Kayser, V. Schulz, P. Drings and H. Bartsch, hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population, Int. J. Cancer 88 (2000), 932-937.
33. H. Sugimura, T. Kohno, K. Wakai, K. Nagura, K. Genka, H. Igarashi, B.J. Morris, S. Baba, Y. Ohno, C. Gao, Z. Li, J. Wang, T. Takezaki, K. Tajima, T. Varga, T. Sawaguchi, J.K. Lum, J.J. Martinson, S. Tsugane, T. Iwamasa, K. Shinmura and J. Yokota, hOGG1 Ser326Cys polymorphism and lung cancer susceptibility, Cancer Epidemiol. Biomarkers Prev. 8 (1999), 669-674.
34. T. Ishida, R. Takashima, M. Fukayama, C. Hamada, Y. Hippo, T. Fujii, S. Moriyama, C. Matsuba, Y. Nakahori, H. Morita, Y. Yazaki, T.Kodama, S. Nishimura and H. Aburatani, NewDNA polymorphisms of human MMH/OGG1 gene: prevalence of one polymorphism among lung-adenocarcinoma patients in Japanese, Int. J. Cancer 80 (1999), 18-21.
35. H. Ito, N. Hamajima, T. Takezaki, K. Matsuo, K. Tajima, S. Hatooka, T. Mitsudomi, M. Suyama, S. Sato and R. Ueda, A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung, J. Epidemiol. 12 (2002), 258-265.
36. L. Le Marchand, T. Donlon, A. Lum-Jones, A. Seifried and L. Wilkens, Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk, Cancer Epidemiol. Biomarkers Prev. 11 (2002), 409-412.